NORCROSS, Ga., October 17, 2016 – Immucor, Inc., a global leader in transfusion and transplantation diagnostics, today announced that it will hold a conference call with debt investors on Friday, October 21, 2016 at 11:00 a.m. ET to discuss its fiscal 2017 first quarter results.
Interested debt investors and analysts should contact Immucor Investor Relations at email@example.com or 770-441-2051 for details.
Founded in 1982, Immucor is a global leader in transfusion and transplantation diagnostics that facilitate patient-donor compatibility. Our mission is to ensure that patients in need of blood, organs or stem cells get the right match that is safe, accessible and affordable. With the right match, we can transform a life together. For more information on Immucor, please visit our website at www.immucor.com.